Clinical Trial Update: Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of Peg-interferon antiviral therapy for chronic hepatitis B in patients with nonalcoholic fatty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Peg-interferon (pegylated interferon alfa)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Nonalcoholic Fatty Liver Disease, Chronic Hepatitis b | Phase 4 | Status: RECRUITING